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Cell Cycle Control; Edited by C. Hutchinson and D.M. Glover, Oxford University Press, New York, 1995. xv + 304 pp. £29.50 (pb). 
ISBN 019 9634106. 
Cdc2 was identified by yeast geneticists nearly twenty ears ago. At that 
time, cell cycle was just an emerging and virgin field of research with 
no need at all for a textbook. Our field has changed rastically since 
sisters of cdc2, the 'cyclin-dependent kinases' (CDK), were discovered 
and a family of cyclin companions was also identified. Cell cycle 
research is now a multidisciplinary field, and every emerging new 
question is enlarging the audience of CDKs. 
The editors C. Hutchinson and D. Glover conclude the preface of 
their book with the following sentence 'We are conscious, as we go to 
press, of the important recent findings that we have been unable to 
cover as the field moves on, but nevertheless we hope that this book 
gives a timely overall perspective on current cell cycle research'. To my 
point of view, the answer is absolutely es. The major difficulty of 
writing a textbook in a field that is moving as fast as the cell cycle has 
during the last decade, is perfectly avoided by the judicious and careful 
choice of the topics that are covered. The editors, who are leaders in 
the field, have commissioned chapters that have been written by experts 
in various aspect of cell cycle research. Indeed, this book not only 
provides a full coverage of all topics, but is enlightening the most 
fascinating advances of recent work. In addition, sufficient background 
is provided with each of the ten chapters to allow the reader to find 
easily the sources of primary data and to search for supplementary 
material. 
The first chapter is an introduction to cell cycle control written by 
L. Hartwell, who initiated genetic work on budding yeast cell division 
cycle mutants in the early 70's. The next one by S. Reed, C. Hutchinson 
and S. MacNeill is a more technical introduction to the concepts and 
the experimental models that have made major contributions to cell 
cycle research. The following two chapters, by S. Reed and by S. 
MacNeill and P. Fantes are dedicated to the review of our current 
knowledge of the molecular mechanisms of control at the G1-S phase 
and the G2-M phase transitions in budding yeast and fission yeast, 
respectively. Chapter 5, by G. Basi and G. Draetta deals with questions 
arising from the study of the cdc2 kinase structure-function 
relationships, and also addresses the role and regulation of this kinase 
in vertebrate c lls. So many kinases, so many cyclins, why? This is one 
of the most fascinating questions that is addressed in chapter 6 of this 
book, by J. Pines and T. Hunter. In chapter 7, J. Blow's contribution 
is an excellent up to date review of the regulation of S-phase. Chapter 
8, by A. Zetterberg and O. Larsson, is dedicated to the study of cell 
growth control in mammalian cells. 
One of the major advances of the last few years has been the 
discovery of several ines of evidence for connecting the molecular 
mechanisms of cell cycle control and cancerogenesis. This evidence is 
clearly reviewed in chapter 9 by E. Lees and E. Harlow. The last 
chapter, by H. White-Cooper and D. Glover beautifully illustrates how 
useful and powerful multicellular organisms can be to investigate 
specific aspects of cell cycle control in connection with developmental 
programs. 
These ten chapters are of equal very good quality and have been 
efficiently compiled, making this a real textbook and not just a 
juxtaposition of specialized reviews. Scientists who do not follow the 
cell cycle literature on a daily basis, newcomers to the field and graduate 
students, all have great difficulty merging and assembling the mass of 
data that has been accumulated in the recent past. I am very much 
convinced that they will enjoy and greatly profit reading this book. So, 
it was time for this new excellent Cell Cycle Control textbook. 
Bernard Ducommun 
Cell Adhesion and Human Disease; Edited by J. Marsh and J.A. Goode, Ciba Foundat ion Symposium 189, Wiley, Chichester, 1995. 
ix + 243 pp. $49.95 (hb). ISBN 0-471-95279-6. 
Adhesion molecules participate in a large number of cellular functions 
and activities. They contribute to normal biological processes and 
disease states uch as cancer (invasion and metastasis), inflammatory 
disorders (rheumatoid arthritis and autoimmune diabetes) and 
cardiovascular diseases (heart attack and stroke). This Ciba 
Foundation Symposium volume contains the papers presented at a 
recent meeting on Cell Adhesion and Human Disease. Each paper is 
followed by a very interesting discussion. The meeting focused on blood 
cell (both leukocyte and platelet)-vessel interactions, but also dealt with 
adhesion molecules in skin and solid tumors. This volume presents 
current research on selectins and their ligands, immunoglobulin-related 
molecules, integrins, cadherins and other adhesion molecules. It also 
considers the therapeutic potential of adhesion molecule antagonists in
inflammatory and malignant diseases. It should be of interest to 
investigators of adhesion molecules, as well as immunologists, 
hematologists and tumor biologists. 
Following a stimulating introduction by R.O. Hynes, chairman of the 
symposium, adhesion molecules mediating blood cell-vessel 
interactions are explored in several chapters and discussions pread 
throughout the volume. Adhesion molecule knockouts, presented in 
two papers, beautifully demonstrate he biological relevance of these 
molecules. Wagner presents the P-selectin (CD62P) knockout and 
demonstrates the importance of this selectin in early leukocyte rolling 
along vascular endothelium and the subsequent leukocyte 
extravasation at inflammatory sites. Kwee et al. present E-selectin 
(CD62E)- and VCAM-1 (CD106)-deficient mice. Participation of E- 
selectin in neutrophil extravasation was less notorious than that of 
P-selectin. In contrast o the selectin knockouts, VCAM-l-deficient 
mice were not viable, indicating the relevance of this molecule during 
development. A human deficiency of the selectin ligand sialyl Le X 
(Sle x, CD15s), known as leukocyte adhesion deficiency (LAD) II, is 
described by Etzioni et al. As in LAD I (f12 integrin-, CD11/CD18- or 
Leu-CAM-deficiency), these patients uffer from recurrent bacterial 
infections. Endogenous protein-associated carbohydrate ligands for E- 
selectin are explored by Patel et al. The authors identify sialyl-di-Lewis 
X as the endogenous ligand. 
Participation of adhesion molecules in detrimental inflammatory 
reactions is also explored following administration of blocking 
monoelonal ntibodies. Winn et al. concentrate on f12 integrins and L 
(CD62L)- and P-selectins in ischemia/reperfusion injury (stroke, 
myocardial infarction, hemorrhagic shock, etc.), while Rothlein and 
Jaeger summarize the effect of anti-ICAM-1 (CD54) antibody in 
animals and humans (allograft rejection and rheumatoid arthritis). 
Both groups report protective ffect of the antibody treatments. Two 
chapters describe progress in leukocyte sill integrin (CD49d/CD29) 
and its ligands fibronectin and VCAM-1. Elices reviews the protective 
effect of antibodies to ~4 in several animal models of allergy and 
chronic inflammatory diseases, and introduces a low molecular weight 
inhibitor of this integrin based on the LDV sequence of fibronectin. 
Humphries et al. dissect he mechanisms of VCAM-1 and fibronectin 
binding to c~4fll, and particularly the peptide sequences participating 
in this and other integrin-ligand interactions. Moreover, Hogg explores 
the binding sites of the integrin ~Lfl2 (CD1 la/CD18) for its ligand 
ICAM-1 and describes that, in addition to the I-domain, domains V 
and VI of c~L also bind ICAM-1. Binding ofvon Willebrand factor to 
specific platelet membrane receptors and its relevance for platelet 
adhesion and thrombus formation at sites of vascular injury are 
summarized by Ruggeri, including the importance of shear forces. 
Up-regulation of vascular adhesion molecules in inflamed skin, a 
process which parallels leukocyte infiltration, is presented by Barker. 
The skin, because of its accessibility, is an ideal organ to study adhesion 
molecule xpression in inflammatory disorders uch as psoriasis and 
atopic dermatitis. Stanley describes two blistering skin diseases 
(pemphigus foliaceus and pemphigus vulgaris) as illustrative xamples 
of defective cell-cell adhesion in the epidermis. These patients' 
autoantibodies to desmogleins, desmosomal g ycoproteins members of 
the cadherin gene superfamily, block adhesion of the epithelial cells. 
Adhesion molecules in human solid tumors are explored in three 
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chapters. Birchmeier et al. report he loss of E-cadherin expression and 
reduced intercellular adhesion in carcinomas, concluding that E- 
cadherin acts as an invasion suppressor. The role of CD44 splice 
variants in metastatic ancer is presented by Sleeman et al. 
Interestingly, the CD44 variants form homomultimeric complexes at 
the cell surface, which may increase their affinity to ligands such as 
hyaluronate. Finally, Pantel et al. describe xpression of cell adhesion 
molecules in early metastasis. The authors conclude that down- 
regulation of desmosomal proteins and neo-expression f ICAM-1 or 
MUC18 are important determinants of the metastatic capability of 
individual malignant cells. 
In summary, this volume presents recent advances in adhesion 
molecule research. The excellent overviews, contributed by leading 
scientists in the field, are complemented with fascinating discussions. 
The book constitutes a most valuable resource in a biomedical research 
library. 
Manuel Patarroyo 
Cytokines in Animal Health and Disease; Edited by Michael J. Myers and Michael P. Murtaugh,  Marcel Dekker, Inc., New York, 
1995. ix + 465 p. $175.00 (hb). ISBN 0-8247-9435-4. 
The scope of this book is the growing field of cytokines in veterinary 
important animals (domestic and companion animals). Whereas 
cytokines have been studied extensively in man and in rodents, the 
investigation ofcytokines in domestic animals has only recently started 
to take pace, fuelled by the growing realization of the importance of 
cytokines in immunological nd inflammatory processes. The aim of 
the editors as stated in the preface of the book is not only to 'review 
the current status of cytokine biology in domestic animals' but also to 
'establish an improved foundation for future research'. 
In the first part of the book, background on cell sources, biological 
effects and receptors, structure and molecular biology of interferons 
(IFN) (I.R. Tizard), interleukin-1 (IL-1) (J.R. Lederer and C.J. 
Czuprynski), IL-2 (M.A. Morsey), tumor necrosis factor (M.J. Myers 
and M.P. Murtaugh) and IL-6 (C.D. Richards and colleagues) are 
described in man and mouse in addition to a summary of comparative 
aspects especially in the bovine, porcine, and ovine species (equine, 
canine, feline, and lapine species are also covered in some of the 
chapters). Generally for these cytokines, wide-spread species-species 
cross-activity is seen (although the IL-1 chapter concludes otherwise). 
The important general conclusion on the therapeutic use of cytokines 
is that they may be more toxic than they are beneficial. In the chapter 
on IL-1, there is no discussion of the more interesting possibility of the 
therapeutic use of natural cytokine inhibitors as e.g. interleukin-1 
receptor antagonist. For some reason dissociation constants are called 
affinity constants in the IFN-chapter. Curiously, sequence data for 
porcine IL-I~ (published in 1990) seem not to be known to the authors 
of the IL-l-chapter (although published in 1990) and also the IL-lfl 
reference is incomplete. In this chapter, too, the homology stated 
between human IL-I receptor antagonist and human, murine and 
bovine IL-1,8 is clearly exaggerated, and the chapter is marred by the 
regular occurrence of nonsensical dissociation constants (around 10 -1 
M). The IL-2 chapter does not mention that the IL-27 receptor also 
binds IL-4 and IL-15, there is not much cross-species information, and 
there is no discussion on measuring IL-2 in animals. In the chapter on 
TNF there is a good discussion of assays, covering the principle of using 
cross-species reacting reagents. The three-dimensional structure of IL- 
6, contrary to what is claimed, is not known. 
In the second part of the book H.P.A. Hughes and L.A. Babiuk 
reviews potentiating the immune response by administering cytokines 
in a vaccine formulation and D.J. Weiss discusses the use of drugs to 
modulate cytokine actions. The authors of the first chapter are quite 
optimistic, even though most of the data deal with IL-2 only. The 
application examples are superficially referred to (in some, the species 
immunized is not even mentioned) and toxic side effects are not 
mentioned. This chapter has a strong point in its good overview of the 
complex interactions taking place between cytokines during a natural 
infection. The drug chapter is short but quite to the point; the concern 
is to limit the adverse ffects of cytokines. 
In the third part of the book specific applications are described in 
which cytokines play major roles or can be used as drugs. There is some 
repetition of facts in this part of the book, e.g. concerning the division 
of TH-Cells into THI and TH2 subsets and the concept of a cytokine 
network. N. Mathialagana and R.M. Roberts describe interferons and 
their role in recognition of pregnancy and fecundity in ruminants. A
practical use of trophoblast IFN (IFN-r), being the messenger molecule 
in cattle and sheep may be confined to special cases like embryo transfer 
methods for sheep as only adverse ffects have been observed with the 
homologue IFN-~ in cattle. M.J. Myers and J.C. Kawalek summarize 
the effects of cytokines on the drug-metabolism of the host. 
Exogenously added cytokines can decrease the drug-metabolizing 
capacity of the body. IFN-~, IL-1, IL-6 and TNF-~ are directly 
involved in cytochrome P450 down-regulation, which is of clear 
relevance considering the widespread use of antibiotics. T.H. Elsasser 
and colleagues present data on the involvement of cytokines in an 
animal's management of stress, a syndrome characterized by changes 
in nutrient use and catabolic delivery and therefore significan~t for the 
economically important growth rate parameter. The practical relevance 
of the cytokine involvement is not clear. H. Bielefeldt-Ohmann a d 
M.J. Wannemuehler describe in two separate chapters both 
pathogenetic and therapeutic aspects of cytokines in microbially 
induced respiratory diseases and in intestinal diseases respectively, 
stressing the detrimental effects of out-of-balance cytokines and 
generally judging therapeutic uses of cytokines as less encouraging. 
Inhibitors (antibodies and soluble receptors and antagonists) are 
expected to be better therapeutic candidates, although the problem of 
timing is a major concern. In some contrast to these two economically 
important diseases, M.B. Tompkins and W.A.F. Tompkins ummarize 
the pathology of retroviruses in the cat. Cytokine therapy in these viral 
diseases i  hampered by the fact that the two viruses (FeLV and FIV) 
reside in the immune system itself. Specifically, the lack of tools for 
lymphocyte subtyping blocks further esearch. The chapter by L.M. 
Sordillo and M.J. Daley returns to the economically important diseases. 
It reviews the possibilities for involvement of cytokines in the 
prevention and therapy of mastitis. The therapeutic use of recombinant 
G-CSF and GM-CSF, IFN- 7 and IL-1 and IL-2 administered in
monstrous doses is presented. The results are characterized as 
'extremely encouraging' but prone to be regulatory/politically sensitive. 
There is no reference to the potential risks of this approach or to the 
costs associated with it. The authors eem to view cytokine therapy as 
a means of cleaning up the mess left by inefficient antibiotics. 
The last two chapters deal with future directions, the first one by E. 
Atac and others discussing relating cytokine expression to disease 
resistance and, by mapping the corresponding enes laying the 
foundation for the selective breeding of preferred cytokine genotypes. 
Knowledge is scarce; cytokines with similar biological effects generally 
map closely on the same chromosome. Only 10 cytokine-related genes 
have hitherto been mapped in the bovine and in cattle and pigs, 
respectively. While selective breeding is a most cost-effective and 
preferable way to combat infections, it is not discussed that with a 
complex system, selecting for a favorable trait may co-select for 
another, unfavorable one. The concluding chapter summarizes that 
cloning of cytokines has primarily been done in swine, cattle and sheep; 
curiously, equine cytokines are not mentioned (genes for IL-1, IL-2, 
IL-4 being sequenced and IL-10 being partly sequenced before time of 
print). Methods are pivotal and their application to new species non- 
trivial. There is a highly readable and important description of the 
various types of assay systems used for the measurement of cytokines. 
With both immunoassays and biological assays there is a need for 
specific antibodies against cytokines. There is also a great need for 
antibodies to define specific subpopulations of e.g. lymphocytes in 
different species. A major future theme is the biological complexity of 
regulation of the cytokine network. Important applications will include 
vaccine technology while the potential of cytokines as therapeutics is 
less obvious. Alternative applications include the use of cytokine 
inhibitors for the restriction of inflammatory reactions, and the 
monitoring of health status by either direct measurement of specific 
